Effective treatment of early triple-negative breast cancer in a patient with sickle cell disease through chemotherapy and immune checkpoint inhibitor therapy: The keynote 522 regimen

Hemoglobin SS (Hb SS) disease is a genetic condition leading to acute and chronic complications in all organ systems. There is limited data on cancer treatment outcomes in this population. This case report presents a woman in her mid-40 s with Hb SS disease and early-stage triple-negative breast can...

Full description

Bibliographic Details

Published in:	Current problems in cancer. Case reports Vol. 20; p. 100393
Main Authors:	Froessl, Luise Josefine, Saxon-Filipe, Stevany, Rambally, Siayareh, Syed, Samira
Format:	Journal Article
Language:	English
Published:	Elsevier Inc 01.12.2025
Subjects:	Hematology, Oncology, and Palliative Medicine Immune checkpoint inhibitor therapy Sickle cell disease Triple negative breast cancer Sickle cell disease Immune checkpoint inhibitor therapy Triple negative breast cancer
ISSN:	2666-6219, 2666-6219
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!